Preparation and Ion Transport Properties of a New TiO2 Dispersed Sodium Ion Conducting Nanocomposite Polymer Electrolytes

Russian Journal of Electrochemistry - Preparation and ion transport property of new Na+ ion conducting nanocomposite polymeric electrolytes (NCPEs): (1 – x)[80PEO:20NaI] + xTiO2, where 0...     

DNA vaccines for cervical cancer: from bench to bedside

More than 99% of cervical cancers have been associated with human papillomaviruses (HPVs), particularly HPV type 16. The clear association between HPV infection and cervical cancer indicates that HPV serves as an ideal target for development of preventive and therapeutic vaccines. Although the recently licensed preventive HPV vaccine, Gardasil, has been shown to be safe and capable of generating significant protection against specific HPV types, it does not have therapeutic effect against established HPV infections and HPV-associated lesions. Two HPV oncogenic proteins, E6 and E7, are consistently co-expressed in HPV-expressing cervical cancers and are important in the induction and maintenance of cellular transformation. Therefore, immunotherapy targeting E6 and/or E7 proteins may provide an opportunity to prevent and treat HPV-associated cervical malignancies. It has been established that T cell-mediated immunity is one of the most crucial components to defend against HPV infections and HPV-associated lesions. Therefore, effective therapeutic HPV vaccines should generate strong E6/E7-specific T cell-mediated immune responses. DNA vaccines have emerged as an attractive approach for antigen-specific T cell-mediated immunotherapy to combat cancers. Intradermal administration of DNA vaccines via a gene gun represents an efficient way to deliver DNA vaccines into professional antigen-presenting cells in vivo. Professional antigen-presenting cells, such as dendritic cells, are the most effective cells for priming antigen-specific T cells. Using the gene gun delivery system, we tested several DNA vaccines that employ intracellular targeting strategies for enhancing MHC class I and class II presentation of encoded model antigen HPV-16 E7. Furthermore, we have developed a strategy to prolong the life of DCs to enhance DNA vaccine potency. More recently, we have developed a strategy to generate antigen-specific CD4(+) T cell immune responses to further enhance DNA vaccine potency. The impressive pre- clinical data generated from our studies have led to several HPV DNA vaccine clinical trials.     

Liquid-phase microextraction-gas chromatography-mass spectrometry for the determination of bromate, iodate, bromide and iodide in high-chloride matrix

In the determination of bromate and iodate, any free bromide and iodide present was quantitatively removed by anion exchange with silver chloride exploiting the differences in silver salts solubility product, being AgCl, 1.8 x 10(-10), AgBr, 5.0 x 10(-13), AgI, 8.3 x 10(-17), AgBrO(3), 5.5 x 10(-5) and AgIO(3), 3.1 x 10(-8). The oxyhalides were reduced with ascorbic acid to halides and converted to 4-bromo-2,6-dimethylaniline and 4-iodo-2,6-dimethylaniline by their reaction with 2-iodosobenzoate in the presence of 2,6-dimethylaniline at pH 6.4 and 2-3, respectively. Single drop microextraction (SDME) of the haloanilines in 2 microl of toluene and injection of the whole extract into GC-MS, or liquid-phase microextraction (LPME) into 50 microl of toluene and injection of 2 microl of extract, resulted in a sensitive method for bromate and iodate. The latter method of extraction has been found more robust, sensitive and to give better extraction in shorter period than SDME. Total bromine/iodine was determined without any treatment with silver chloride. High concentration of chloride in the matrix did not interfere. A rectilinear calibration graph was obtained for 0.05 microg-25 mg l(-1) of bromate/bromide and iodate/iodide, the limit of detection were 20 ng l(-1) of bromate, 15 ng l(-1) of iodate, 20 ng l(-1) of bromide and 10 ng l(-1) of iodide (by LPME in 50 microl of toluene). The method has been applied to seawater and table salt. From the pooled data, the average recovery of spiked oxyhalide/halide to real samples was in range 96.7-105.7% with RSD in range 1.6-6.5%.     

Unimolecular rectification of monolayers of CH3C(O)S-C14H28Q(+)-3CNQ(-) and CH3C(O)S-C16H32Q(+)-3CNQ(-) organized by self-assembly, Langmuir-Blodgett, and Langmuir-Schaefer techniques

The advantage of "self-assembly" (strong covalent binding to substrates) was combined with the advantage of Langmuir-Blodgett (LB) or Langmuir-Schaefer (LS) transfer to a solid substrate (quantitative transfer of monolayers to the substrate). The electrical rectification (asymmetric conduction) by a monolayer of thioacetylalkylquinolinium tricyanoquinodimethanide was critically compared when these molecules had been transferred, by such competing techniques, onto gold electrodes, and then covered by a "cold gold" pad electrode. Unimolecular rectification was observed in the expected directions in the LB and LS monolayers. The Self-Assembled Monolayers (SAMs) were disordered; macroscopic measurements of rectification were unsuccessful for the SAMs, but successful for the down-stroke LB and LS monolayers, whose orientation and potential bonding to the Au surface should be identical to that of an ideal SAM.     

Recent advances in applications of single-drop microextraction: a review

During the past fifteen years since its introduction, single-drop microextraction has witnessed incessant growth in the range of applications of samples preparation for trace organic and inorganic analysis. This was mainly due to the array of modes that are available to accomplish extraction in harmony with the nature of analytes, and to use the extract directly for analysis by diverse instrumental methods. Whilst engineering of novel sorbent materials has expanded the sample capabilities of rival method of solid-phase microextraction, the single-drop microextraction – irrespective of the mode of extraction – uses common equipment found in analytical laboratories sans any modification, and in a much economic way. The recent innovations made in the field, as highlighted in this review article in the backdrop of historical developments, are due to the freedom in operational conditions and practicability to exploit chemical principals for optimum extraction and sensitive determination of analytes. Literature published till July 2011 has been covered.     

Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132

The aim of this work was to prepare chitosan nanoparticles loaded with antineoplastic drug Lomustine (LCNPs), by ionic-gelation method with homogenization. The nanoparticles were characterized for particle size, polydispersity index (PDI), surface morphology, encapsulation efficiency, in-vitro drug release and cytotoxicity on human lung cancer cell line L132 by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The particle size, zeta potential and encapsulation efficiency of prepared nanoparticles ranged from 75 ± 1.1 to 637 ± 1.6 nm (PDI from 0.05 ± 0.001 to 0.18 ± 0.007), 37.2 ± 0.21 to 53.8 ± 0.18 mV and 66.74 ± 1.4 to 98.0 ± 1.8% respectively. The particles were spherical in shape with smooth surface in scanning electron microscopy (SEM) and transmission electron microscopy (TEM) images. Mechanical shearing by homogenization treatment significantly changed the nanoparticle size. The drug release rate was biphasic and diffusion controlled over the 8 h. LCNPs greatly inhibited the growth of the L132 cancer cell line used in this study in comparison to the native Lomustine (LMT).     

LC-MS/TOF, LC-MSn, on-line H/D exchange and LC-NMR studies on rosuvastatin degradation and in silico determination of toxicity of its degradation products: a comprehensive approach during drug development

The present study dealt with the forced degradation behaviour of rosuvastatin under ICH prescribed stress conditions. The drug was found to be labile under acid hydrolytic and photolytic conditions, while it was stable to base/neutral hydrolytic, oxidative and thermal stress. In total, 11 degradation products were formed, which were separated on a C-18 column using a stability-indicating method. LC-MS analyses indicated that five degradation products had the same molecular mass as that of the drug, while the remaining six had 18 Da less than the drug. Structure elucidation of all the degradation products was executed using sophisticated and modern structural characterization tools, viz. LC-MS/TOF, LC-MSⁿ, on-line H/D exchange and LC-NMR. The degradation pathway and mechanisms of degradation of the drug were delineated. Additionally, in silico toxicity was predicted for all the degradation products using TOPKAT and DEREK software and compared with the drug. This study demonstrates a comprehensive approach of degradation studies during the drug development phase.

Synchrotron μ‐XRF study on compositional uniformity of uranium–thorium oxide pellets prepared by different processes

A μ‐XRF study to assess the distribution of uranium and thorium in (U,Th)O₂ pellets covering the composition of advanced heavy water reactor (AHWR) fuel pellets prepared by powder metallurgical compaction (PMC) and coated agglomerate pelletization (CAP) routes was made using micro‐focus beam line (BL‐16) of Indus‐2 synchrotron radiation facility. The methodology thus developed was successfully applied to these pellets. The study reveals that the uranium distribution in pellets prepared by PMC route is uniform, whereas the pellets prepared through CAP route have a wide range of compositional variation. In addition, the uniformity in CAP route‐prepared pellets improves with increase in the relative amount of uranium in the pellets. The sample preparation in present methodology is very simple compared with scanning electron microscopy. The study reveals the utility of synchrotron‐based μ‐XRF for fuel pellet characterization of AHWR reactors. Alhough CAP route of fuel pellet preparation requires less exposure of personnel to high radiation dose, the non‐uniformity in the fuel pellet must be considered when using these pellets in reactors. Copyright © 2014 John Wiley & Sons, Ltd.     

Single vial formulation for theranostic radiopharmaceutical preparation

The present work was aimed at development of pharmaceutical grade single vial kit like formulation of somatostatin analogue, DOTA–Tyr³–Thr⁸-Octreotide (DOTATATE) suitable for radiolabeling with both diagnostic (⁶⁸Ga) and therapeutic (¹⁷⁷Lu) radioisotope. Single vial kit like formulation of DOTATATE was prepared. Radiolabeling methods with ⁶⁸Ga and ¹⁷⁷Lu were standardized. The pharmaceutical purity and stability of formulation was studied over a period of 6 months. Pharmacokinetics of radiolabeled preparations was studied in Swiss mice. DOTATATE formulation with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer was successfully prepared. Both ⁶⁸Ga–DOTATATE and ¹⁷⁷Lu–DOTATATE complexes were formed with >95 % radiochemical purity. Biodistribution studies of ⁶⁸Ga–DOTATATE and ¹⁷⁷Lu–DOTATATE complexes in Swiss mice revealed fast clearance of activity via renal route. Single vial kit like formulation suitable for easy preparation of ⁶⁸Ga–DOTATATE and ¹⁷⁷Lu–DOTATATE at hospital radiopharmacy was successfully demonstrated.     

Probiotic Escherichia coli CFR 16 Producing Pyrroloquinoline Quinone (PQQ) Ameliorates 1,2-Dimethylhydrazine-Induced Oxidative Damage in Colon and Liver of Rats

Inflammation of the gastrointestinal tract is associated with reactive oxygen species (ROS) genesis. Alleviation of oxidative stress is achieved by using antioxidants and probiotics. Present study investigates a synergistic effect of the probiotic Escherichia coli CFR 16 containing Vitreoscilla haemoglobin gene (vgb), green fluorescent protein (gfp) gene and pyrroloquinoline quinone (pqq) gene cluster on oxidative stress induced by 1,2-dimethylhydrazine (DMH). Adult virgin Charles foster male rats (3–4 months) weighing 200–250 g were administered with DMH (25 mg/kg body weight, s.c.) twice a week for eight consecutive weeks. Rats receiving only DMH dose showed increased lipid peroxidation in liver and intestinal tissues with reduced activity of antioxidant enzymes, i.e. superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx). Oral dose of E. coli CFR 16::vgb-gfp harbouring pqq gene cluster increased rat faecal PQQ concentration by twofold, reduced lipid peroxidation and retained SOD, CAT and GPx activities close to normal levels in liver and colonic tissues following DMH treatment. In addition, significant protection was found in colonic histological sections of these rat groups. This study demonstrates a protective efficacy in the following order: E. coli CFR 16?<?E. coli CFR 16::vgb-gfp?<?vitamin C?=?PQQ?<?E. coli CFR 16::vgb-gfp (pqq).